Ixempra Approved for Breast Cancer
618283
WEDNESDAY, Oct. 17 (HealthDay News) -- A new chemotherapy drug called Ixempra has received U.S. Food and Drug Administration approval to treat women with advanced breast cancer who haven't responded to three other types of chemotherapy.
339598
Novartis AG      won U.S. approval to promote the drug Femara for women who have finished standard therapy for early-stage breast cancer and run out of options, the company said on Friday.
40663
SAN ANTONIO -- Doctors say a newer class of drugs is showing better results in preventing the return of breast cancer than the more traditional drug, tamoxifen.
557014
Adding Herceptin to chemotherapy before surgery eradicates tumors in nearly three times as many women with inflammatory breast cancer as chemotherapy alone, the drug's maker Roche Holding AG said on Wednesday.
530863
The US Food and Drug Administration (FDA) approved a new genetic test of the likelihood of recurring breast cancer, five to ten years after its onset.
36374
The FDA has approved the drug letrozole for use in postmenopausal women with early breast cancer who have completed standard adjuvant tamoxifen therapy.
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.
53226
THE REPORT: Doctors are reporting that a new breast cancer drug, Arimidex, and others in its class outperform the tried-and-true tamoxifen at preventing recurrence in older women.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
13553
Post-menopausal women diagnosed with early-stage hormone-receptor (HR) positive breast cancer might be better off taking the drug anastrozole (Arimidex - brand name
415904
LONDON - Arimidex, one of a new class of breast cancer drugs, has clearly beaten standard treatment tamoxifen at preventing breast cancer from returning in a 5-year study, researchers said on Wednesday.
234104
SILVER SPRING, Md.  - A panel of medical experts  on Wednesday recommended approval for Ilex Oncology Inc.'s new  drug Clolar for use against one type of leukemia but not  against another.
477676
The drug toremifene, used to treat breast cancer in women, has been found to also reduce the incidence of prostate cancer in men at risk for the disease.
388672
Eli Lilly & Co  said on Friday that it had won approval to market its blockbuster osteoporosis drug to post-menopausal women who are at high risk for invasive breast cancer.
411375
GlaxoSmithKline Plc  won U.S. approval for a once-a-day breast cancer pill on Tuesday that the drugmaker hopes will launch a new era for its oncology business.
57060
WASHINGTON -- Women with an aggressive form of advanced breast cancer that other treatments have failed to stop gained a new option yesterday with the approval of a novel drug -- but how much benefit it offers is unclear.
157177
WASHINGTON The Food and Drug Administration has agreed to allow broader application of a breast cancer drug. The drug (letrozole) is currently used against advanced breast cancer and the FDA will now allow